Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−4.24 USD
−6.53 M USD
5.90 M USD
1.46 M
About NeuroMetrix, Inc.
Sector
Industry
CEO
Shai N. Gozani
Website
Headquarters
Woburn
Founded
1996
FIGI
BBG000BB88M2
NeuroMetrix, Inc. engages in the development and manufacture of diagnostic and therapeutic neurostimulation-based medical devices. Its products include DPNCheck, Quell, and ADVANCE system. It also focuses on the sale of medical equipment and consumables. The company was founded by Shai N. Gozani in June 1996 and is headquartered in Woburn, MA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of NURO is 4.34 USD — it has increased by 9.32% in the past 24 hours. Watch NeuroMetrix, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange NeuroMetrix, Inc. stocks are traded under the ticker NURO.
NURO stock has risen by 17.93% compared to the previous week, the month change is a −5.24% fall, over the last year NeuroMetrix, Inc. has showed a 13.02% increase.
NURO reached its all-time high on Apr 21, 2006 with the price of 3,796,070.40 USD, and its all-time low was 2.66 USD and was reached on Aug 13, 2024. View more price dynamics on NURO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
NURO stock is 15.15% volatile and has beta coefficient of 0.44. Track NeuroMetrix, Inc. stock price on the chart and check out the list of the most volatile stocks — is NeuroMetrix, Inc. there?
Today NeuroMetrix, Inc. has the market capitalization of 8.87 M, it has increased by 10.58% over the last week.
Yes, you can track NeuroMetrix, Inc. financials in yearly and quarterly reports right on TradingView.
NeuroMetrix, Inc. is going to release the next earnings report on Jan 23, 2025. Keep track of upcoming events with our Earnings Calendar.
NURO net income for the last quarter is −1.51 M USD, while the quarter before that showed −1.49 M USD of net income which accounts for −1.36% change. Track more NeuroMetrix, Inc. financial stats to get the full picture.
No, NURO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 26.00 employees. See our rating of the largest employees — is NeuroMetrix, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NeuroMetrix, Inc. EBITDA is −8.48 M USD, and current EBITDA margin is −120.24%. See more stats in NeuroMetrix, Inc. financial statements.
Like other stocks, NURO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NeuroMetrix, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NeuroMetrix, Inc. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NeuroMetrix, Inc. stock shows the sell signal. See more of NeuroMetrix, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.